Salamzade R, McElheny CL, Manson AL, Earl AM, Shaikh N, Doi Y. Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic among children in the United States. mSphere. 2023:e0018423. doi:10.1128/msphere.00184-23.

Tang W, Bobeica SC, Wang L, van der Donk WA. CylA is a sequence-specific protease involved in toxin biosynthesis. J Ind Microbiol Biotechnol. 2019;46(3-4):537-549. doi:10.1007/s10295-018-2110-9.

Cardoso MH, Cândido ES, Chan LY, et al. A Computationally Designed Peptide Derived from Escherichia coli as a Potential Drug Template for Antibacterial and Antibiofilm Therapies. ACS Infect Dis. 2018;4(12):1727-1736. doi:10.1021/acsinfecdis.8b00219.

Worby CJ, Schreiber HL, Straub TJ, et al. Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women. Nat Microbiol. 2022;7(5):630-639. doi:10.1038/s41564-022-01107-x.

Andrews LB, Nielsen AAK, Voigt CA. Cellular checkpoint control using programmable sequential logic. Science. 2018;361(6408). doi:10.1126/science.aap8987.

Yu H, Rosen MK, Shin TB, Seidel-Dugan C, Brugge JS, Schreiber SL. Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science. 1992;258(5088):1665-8.

Rajavelu A, Lungu C, Emperle M, et al. Chromatin-dependent allosteric regulation of DNMT3A activity by MeCP2. Nucleic Acids Res. 2018;46(17):9044-9056. doi:10.1093/nar/gky715.

Standaert RF, Galat A, Verdine GL, Schreiber SL. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature. 1990;346(6285):671-4. doi:10.1038/346671a0.

Johns NI, Gomes ALC, Yim SS, et al. Metagenomic mining of regulatory elements enables programmable species-selective gene expression. Nat Methods. 2018;15(5):323-329. doi:10.1038/nmeth.4633.

Rosen MK, Standaert RF, Galat A, Nakatsuka M, Schreiber SL. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate. Science. 1990;248(4957):863-6.